home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Therapeutic RNA Interference In Neurodegenerative Disease

  July, 12 2007 8:46
your information resource in human molecular genetics
In a review article in the July 2007 issue of Nature Clinical Practice Neurology, Pedro Gonzalez-Alegre and Henry L. Paulson consider how RNA interference (RNAi) technology might be exploited to treat neurodegenerative diseases that are currently incurable, such as Huntington's disease, Alzheimer's disease and spinocerebellar ataxia.

The RNAi gene regulatory pathway could potentially suppress the expression of a wide range of disease-causing mutant genes. Initial studies of therapeutic RNAi in cell-based and animal models of neurodegenerative disease have produced encouraging results, and human trials are expected to be initiated within the next few years.

Andrew Fire and Craig Mello won the 2006 Nobel Prize in Physiology or Medicine for the discovery of the RNAi pathway. Since their landmark paper was published in 1998, RNAi has become a powerful tool for biological research, enabling virtually any target gene to be suppressed in a sequence-specific manner. In the current article, Gonzalez-Alegre and Paulson highlight the challenges involved in bringing RNAi to the neurology clinic, including safe and efficient delivery of the therapeutic RNAi agent, and the development of reliable measures of treatment efficacy.

Author contact:

Henry L. Paulson (University of Michigan Medical School, Ann Arbor, MI, USA)
E-mail: henry-paulson@uiowa.edu

Editor contact:

Heather Wood (Editor, Nature Clinical Practice Neurology)
E-mail: h.wood@nature.com

Abstract available online.

(C) Nature Clinical Practice Neurology press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.